Oncology Nurses as Patient Advocates

Article

Oncology nurses can make the world of a difference when it comes to patient care, and it is crucial that they work together with other members of the treatment team to ensure the best outcomes, according to Sally Werner, MSHA, BSN, RN, senior vice president, affiliate relations at Cancer Support Community.

Oncology nurses can make the world of a difference when it comes to patient care, and it is crucial that they work together with other memebers of the treatment team to ensure the best outcomes, according to Sally Werner, MSHA, BSN, RN, senior vice president, affiliate relations at Cancer Support Community.

In this month’s episode of the CURE Talks Cancer Podcast: Nursing Edition, Werner — an oncology nurse by trade – discusses how nurses can be the best advocates for their patients, how to navigate life in the era of “Dr. Google,” and more.

Recent Videos
Image of a woman with glasses wearing a striped blouse and a black sweater in front of an Oncology Nursing News branded backdrop
Screenshot of Kiah Purcell, MSN, AGPCNP-BC, in a video call with the frame surrounded by an Oncology Nursing News branded border
Photo of Jamie Carroll, APRN, CNP, MSN, from a video call with an Oncology Nursing News branded border around the frame
5 experts in this video
Image of Kayle Freeman, DNP, APRN, FNP-C, in a video call with an Oncology Nursing News border around the frame
Image of Jessie Desir, PhD, RN, AMB-BC, OCN, in a video call with a blue and gold Oncology Nursing News border surrounding the frame.
Related Content
Blue rendering of a stomach leading to the esophagus

Perioperative Durvalumab With Chemo for Resectable Gastric/GEJ Cancer Reaches EFS End Point

Chris Ryan
March 21st 2025
Article

Neoadjuvant and adjuvant durvalumab plus FLOT followed by durvalumab monotherapy improved EFS for patients with resectable gastric or GEJ cancer.

The Vitals

What New Cancer Drugs Were Approved in 2023?

Lindsay Fischer
January 1st 2024
Podcast

In this special episode of The Vitals, we ring in the New Year 2024 by combing through 2023 FDA approvals.

Rendering of plasma cells

Daratumumab-Based Regimen Sustains Efficacy in Transplant-Ineligible NDMM

Russ Conroy
March 20th 2025
Article

Updated MAIA trial results reinforce the frontline benefit of daratumumab plus lenalidomide/dexamethasone in transplant-ineligible NDMM.

The Vitals

Finley-Oliver Talks Talquetamab and Other Later Line Multiple Myeloma Therapies

Lindsay Fischer
December 14th 2023
Podcast

Beth Finley-Oliver, MSN, ARNP, AGNP-BC, recaps part of her presentation from the 2023 JADPRO meeting about caring for patients with high-risk multiple myeloma.

Aerial photo of four medical professionals talking in a huddle; two are wearing scrubs and two are wearing lab coats

Shared Model of Care Post-HCT Offers Safe Follow-Up, Reduces Patient Burden

Bridget Hoyt
Published: March 19th 2025 | Updated: March 19th 2025
Article

Alternating post-HCT care between specialized facilities and local cancer centers produced noninferior non-relapse mortality and similar quality of life to usual care.

Graphic of a lymphoma cell

Cema-Cel Yields CR, Found Tolerable in CD19 CAR T-Cell Therapy–Naive R/R LBCL

Courtney Flaherty
March 18th 2025
Article

Cema-cel was associated with largely durable CRs in patients with CD19 CAR T-cell therapy-naïve relapsed/refractory LBCL.